131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients-Reference-Cited by-同舟云学术

131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients

Published:2008-08-14 Issue:9 Volume:49 Page:1445-1450
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Remy Hervé,Borget Isabelle,Leboulleux Sophie,Guilabert Nadine,Lavielle Frédéric,Garsi Jérome,Bournaud Claire,Gupta Séverine,Schlumberger Martin,Ricard Marcel

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. Papillary and Follicular Thyroid Carcinoma

2. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium

3. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce

4. Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenazine Porous Polymers for Radioactive Iodine Capture;Lecture Notes in Mechanical Engineering;2024

2. Schilddrüse (peripher);Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel;2024

3. Comparison of Whole-Body Dosimetry Measurements in ¹³¹I Therapy Using Ceiling-Mounted Geiger–Müller Detectors and γ-Camera Scans: An Agreement Analysis;Cancer Biotherapy and Radiopharmaceuticals;2023-09-01

4. Absorbed dose coefficients for adult thyroid cancer patients undergoing radioiodine therapy;Journal of Radiological Protection;2023-05-25

5. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies;European Journal of Endocrinology;2023-01-19